Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep633 | Pituitary and Neuroendocrinology | ECE2020

ACTH-secreting pituitary tumor with delayed aggressive clinical recurrence – management challenges

Gaita Isabela , Cristescu Alexandru , Enculescu Augustina , Poiana Catalina , Radian Serban

Background: Pituitary adenomas (PA) are slow-growing, benign intracranial tumors. Rarely, they can be histologically and clinically aggressive.Aim: To present a case of corticotroph PA with aggressive behavior following a long indolent interval after the initial surgery.Case presentation: A 47 years old female presented in Nov 2007 with right temporal hemianopsia and left eye blindness, associating type 2 DM and severe mixed dyslip...

ea0067gp16 | Poster Presentations | EYES2019

Association of adrenal cortisol-producing adenoma and invasive papillary thyroid carcinoma in an older patient: coincidence or multiple endocrine neoplasia (MEN)?

Iancu Cristina , Gaita Isabela , Tomulescu Victor , Iorgulescu Radu , Capatina Cristina , Radian Serban , Poiana Catalina

Background: Association of differentiated thyroid carcinoma (DTC) and cortisol-producing adrenal adenoma is not part of the classical MEN syndromes. We present a clinical case raising the question of a common etiology for these tumours.Case Presentation: A 58-year-old female presented in 2010 for the investigation of a 6 cm left adrenal tumour incidentally discovered by abdominal CT. Medical history included smoking, obesity, myocardial infarction, hyper...

ea0070aep32 | Adrenal and Cardiovascular Endocrinology | ECE2020

A rare case of functioning adrenocortical oncocytoma of uncertain malignant potential in a young female diagnosed with type 1 neurofibromatosis

Gaita Isabela , Iorgulescu Radu , Cristina Terzea Dana , Danau Razvan , Poiana Catalina , Radian Serban

Background: Adrenocortical oncocytoma is a veryrare adrenal tumor type, usually nonfunctioning and benign. Neurofibromatosistype 1 (NF1) is an autosomal dominant disease caused by mutations of the NF1 gene encoding neurofibromin, a tumor supressor gene that acts by activating a RAS GTP-ase which negatively regulates RAS activity. NF 1 is usually associated with pheocromocytoma, rarely with adrenal carcinoma, and no association with adrenal oncocytoma has been reported.<p c...